Gustave Roussy is the first leader cancer-research hospital in Europe and ranked among the top 3 best specialized hospitals in the world . It is a centre for high quality patient care, research and teaching. It is highly-known for the treatment of (among others): skin cancers like melanoma, breast cancer, and lung cancer. It provides access to care with many expert doctors who have historically revolutionized the treatment of cancer and contributed to the surge of new molecules in the treatment of cancers and tumors. It is located in the Parisian area. It is named after Gustave Roussy, a Swiss-French neuropathologist.
In April 2019, three new interventional radiology rooms were inaugurated, making it the largest platform of this type in Europe, entirely dedicated to oncology. Interventional radiology is a so-called "minimally invasive" diagnostic and treatment technique, which uses images to guide access to deep-lying organs, without having to "open up" patients. Gustave Roussy carries out more than 4,000 operations of this type each year.[1]
Barbara Tudek (1952-2019), biologist and professor who served as president of the Polish section of the European Environmental Mutagenesis and Genomics Society
Gustave-Roussy School of Cancer Sciences
Together with the Faculty of Medicine of the University of Paris-Saclay, the Gustave-Roussy Institute runs the School of Cancer Sciences, a university establishment specializing in oncology. The lessons take place at the Cancer Campus in Villejuif in the Val-de-Marne.
In the various courses offered by the faculty of medicine (adult, adolescent and child oncology; surgery; best practices; medical imaging; radiotherapy; other courses), the establishment integrates the Doctoral School of Oncology, Biology, Medicine, Health (and its Master 2 in Biology and Health, Cancerology specialty) created with the École Normale Supérieure Paris-Saclay.[3]
Directed in 2015 by Pierre Blanchard, the school had trained nearly 2,800 students and awarded twenty-six university degrees.[3]
Awards and Rankings
In 2020, the Institut Gustave Roussy was ranked as the first leading cancer hospital in Europe and in the top 5 best specialized hospitals in the world.[4]
Incidents
In 2017, a virologist from the Institut Gustave Roussy was sentenced to 5 years in prison for poisoning colleagues with sodium azide in 2014.[5]
Institut Curie is a medical, biological and biophysical research centre in France. It is a private non-profit foundation operating a research center on biophysics, cell biology and oncology and a hospital specialized in treatment of cancer. It is located in Paris, France.
The Leopold Griffuel Prize for translational and clinical research is sponsored by the French ARC Foundation for Cancer Research.
Gustave Roussy was a Swiss-French neuropathologist born in Vevey, Switzerland.
Assistance Publique–Hôpitaux de Paris (AP-HP) is the university hospital trust operating in Paris and its surroundings. It is the largest hospital system in Europe and one of the largest in the world. It receives an average of more than 10 million patients per year.
Kunming Medical University, previously known as Kunming Medical College, is a medical school located in Kunming City, Yunnan Province, China.
Ralph Weissleder is an American clinician scientist.
Georges Mathé was a French oncologist and immunologist. In November 1958, he performed the first successful allogeneic bone marrow transplant ever performed on unrelated human beings.
Ann Barrett OBE, is Emeritus Professor of Oncology in the University of East Anglia, England, and formerly deputy dean of the School of Medicine and lead clinician for oncology at the Norfolk and Norwich University Hospital NHS Trust. She was awarded an OBE in 2010 for services to medicine. She is also a fellow of the Royal College of Surgeons in Ireland.
Michael John Peckham was a British oncologist and artist. As a cancer physician he is best known for his contribution to the treatment of testicular cancer. His paintings were first exhibited in 1962 and he showed in numerous mixed and solo exhibitions.
The Institut Sup'Biotech de Paris is a French private engineering school created in 2003, located in Villejuif, near Paris, and in Lyon.
Cancer Campus is a research and innovative campus in oncology located in Villejuif, close to Paris, and launched in April 2006. It is devoted to help to fight cancer.
Frédéric Triebel is a French immunologist who is best known for his 1990 discovery of the LAG3 immune control mechanism. Triebel worked through the 1990s in a collaboration between Institut Gustave Roussy and Merck Serono to establish LAG-3's mechanism of action in T cells and dendritic cells. In 2001 he founded Immutep SA, a biotech company, to develop the therapeutic potential of LAG3. In 2014 this company was acquired by Prima BioMed, where Triebel remains Chief Scientific and Medical Officer.
Odile Schweisguth (1913-2002) was a French physician who is considered the pioneer of pediatric oncology in Europe and was the founder of the first child cancer department at the Institut Gustave Roussy (IGR) in Villejuif.
The Organisation of European Cancer Institutes (OECI) is an international non-profit organization with European Economic Interest Grouping status. It was created in 1979 to promote greater cooperation among European cancer centers and institutes. Its head office is located in Brussels at the Belgian University Foundation.
The René Huguenin Hospital is a renowned teaching hospital in Saint-Cloud, France. Part of the Curie Institute and a teaching hospital of Versailles Saint-Quentin-en-Yvelines University.
Jean Paul Thiery is a French biologist born on 25 April 1947. He is director of emeritus research at the CNRS-Paris-Diderot University laboratory on complex materials and systems, at the Institut Gustave Roussy's cancer centre and associate professor at several foreign universities.
Laurence Zitvogel is a French physician specializing in oncology and immunology with a large research experience in exosomes and the biological impact of those structures in malignant neoplasms.
The University Hospital Mannheim is a maximum care hospital with many specialisations. It currently consists of 21 specialised clinics, all situated on a historic campus in the centre of Mannheim and focuses on interdisciplinary and interprofessional cooperation of its physicians in the treatment of its patients.
Sophie Postel-Vinay is a French physician and scientist at the Institut Gustave Roussy where she has led an ATIP-Avenir team since 2018. She works on oncology and the development of new drugs and is an expert in early clinical trials. She was the 2019 winner of the Irène Joliot-Curie Prize in the “young woman scientist” category.
Malabar Cancer Centre (MCC) in Thalassery, Kannur district is an autonomous not-for-profit institution under Health and Family Welfare Department, Government of Kerala. In June 2022, the institute was upgraded to Post Graduate Institute of Oncology Sciences and Research.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
